Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **ATP-sensitive potassium channel complex** is a hetero-octameric integral membrane protein complex composed of four inward-rectifier potassium channel subunits (Kir6.1 or Kir6.2) and four regulatory sulfonylurea receptor (SUR1, SUR2A, or SUR2B) subunits. It **acts as a metabolic sensor in tissues including pancreas, heart, muscle, and brain, coupling the cellular ATP/ADP ratio to membrane excitability**. In pancreatic beta cells, it regulates insulin secretion in response to blood glucose by controlling membrane potential. The channel is closed by ATP (signifying metabolic sufficiency) and opened by Mg-ADP (especially via the SUR subunit, signifying energy deficit), thereby linking metabolism to cellular electrical activity[4][1][2][3][6][7]. The complex is both a major **therapeutic target** in diabetes (sulfonylureas, meglitinides), and in cardiovascular disease (K_ATP channel openers). Mutations in its subunits cause congenital disorders of insulin regulation as well as cardiac and neurological phenotypes.
Sulfonylureas: Binding to the sulfonylurea receptor (SUR) inhibits channel activity, leading to increased membrane depolarization and enhanced insulin secretion[6][5] Diazoxide and other openers: Bind to regulatory sites and stabilize the open conformation, hyperpolarizing the cell membrane and reducing insulin secretion (counteracts hypoglycemia)[4] Nucleotide-modulated gating: ATP binding inhibits channel opening; Mg-ADP binding (to SUR) activates channel opening[4][3]
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP-sensitive potassium channel complex (K_ATP channel or K_ATP channel complex).